| # | Drug | Count |
|---|---|---|
| 0 | ZIDOVUDINE | 26 |
| 1 | LAMIVUDINE | 21 |
| 2 | LAMIVUDINE ORAL | 19 |
| 3 | NEVIRAPINE | 14 |
| 4 | VALACYCLOVIR | 10 |
| 5 | VALACYCLOVIR HYDROCHLORIDE | 10 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE | 6 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 4 |
| 8 | ALPRAZOLAM | 3 |
| 9 | AZITHROMYCIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HEPATITIS B IMMUNE GLOBULIN (HUMAN) | 1 | 0.0196 |
| 1 | ZIDOVUDINE | 26 | 0.0025 |
| 2 | NEVIRAPINE | 14 | 0.0016 |
| 3 | PORACTANT ALFA | 1 | 0.0014 |
| 4 | LAMIVUDINE | 21 | 0.0008 |
| 5 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 4 | 0.0005 |
| 6 | CLINDAMYCIN PHOSPHATE | 2 | 0.0004 |
| 7 | OXYTOCIN | 1 | 0.0003 |
| 8 | CEFIXIME | 1 | 0.0003 |
| 9 | RILPIVIRINE | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 1 | Surfactant [EPC] | 1 | 0.0009 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 14 | 0.0006 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 21 | 0.0004 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 38 | 0.0003 |
| 5 | Oxytocic [EPC] | 1 | 0.0003 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Antimalarial [EPC] | 2 | 0.0002 |
| 8 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 9 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |